↓ Skip to main content

Adapting and testing a brief intervention to reduce maternal anxiety during pregnancy (ACORN): study protocol for a randomised controlled trial

Overview of attention for article published in Trials, March 2016
Altmetric Badge

Mentioned by

twitter
16 X users

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
334 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Adapting and testing a brief intervention to reduce maternal anxiety during pregnancy (ACORN): study protocol for a randomised controlled trial
Published in
Trials, March 2016
DOI 10.1186/s13063-016-1274-8
Pubmed ID
Authors

Esther L. Wilkinson, Heather A. O’Mahen, Pasco Fearon, Sarah Halligan, Dorothy X. King, Geva Greenfield, Jacqueline Dunkley-Bent, Jennifer Ericksen, Jeannette Milgrom, Paul G. Ramchandani

Abstract

National guidelines in the UK, United States of America, Canada, and Australia have recently stressed the importance of identifying and treating antenatal anxiety and depression. However, there is little research into the most effective and acceptable ways of helping women manage their symptoms of anxiety and stress during pregnancy. Research indicates the necessity to consider the unique needs and concerns of perinatal populations to ensure treatment engagement, highlighting the need to develop specialised treatments which could be integrated within routine antenatal healthcare services. This trial aims to develop a brief intervention for antenatal anxiety, with a focus on embedding the delivery of the treatment within routine antenatal care. This study is a two-phase feasibility trial. In phase 1 we will develop and pilot a brief intervention for antenatal anxiety, blended with group support, to be led by midwives. This intervention will draw on cognitive behavioural principles and wider learning from existing interventions that have been used to reduce anxiety in expectant mothers. The intervention will then be tested in a pilot randomised controlled trial in phase 2. The following outcomes will be assessed: (1) number of participants meeting eligibility criteria, (2) number of participants consenting to the study, (3) number of participants randomised, (4) number of sessions completed by those in the intervention arm, and (5) number of participants completing the post-intervention outcome measures. Secondary outcomes comprise: detailed feedback on acceptability, which will guide further development of the intervention; and outcome data on symptoms of maternal and paternal anxiety and depression, maternal quality of life, quality of couple relationship, mother-child bonding, infant temperament and infant sleep. The study will provide important data to inform the design of a future full-scale randomised controlled trial of a brief intervention for anxiety during pregnancy. This will include information on its acceptability and feasibility regarding implementation within current antenatal services, which will inform whether ultimately this provision could be rolled out widely in healthcare settings. Current Controlled Trials ISRCTN95282830 . Registered on 29 October 2014.

X Demographics

X Demographics

The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 334 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 <1%
Canada 1 <1%
Unknown 332 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 62 19%
Student > Ph. D. Student 46 14%
Student > Bachelor 37 11%
Researcher 26 8%
Student > Postgraduate 16 5%
Other 57 17%
Unknown 90 27%
Readers by discipline Count As %
Psychology 85 25%
Nursing and Health Professions 58 17%
Medicine and Dentistry 45 13%
Social Sciences 16 5%
Neuroscience 6 2%
Other 31 9%
Unknown 93 28%